Chemoinformaics analysis of N-[(E)-2-(4-methoxyphenyl)ethenyl]benzamide
| Molecular Weight | 253.301 | nRot | 4 |
| Heavy Atom Molecular Weight | 238.181 | nRig | 14 |
| Exact Molecular Weight | 253.11 | nRing | 2 |
| Solubility: LogS | -3.629 | nHRing | 0 |
| Solubility: LogP | 2.697 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 15 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 12 |
| nHA | 2 | APOL | 39.4259 |
| nHD | 1 | BPOL | 18.2221 |
| QED | 0.785 |
| Synth | 2.037 |
| Natural Product Likeliness | -0.374 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.125 |
| Pgp-sub | 0.001 |
| HIA | 0.009 |
| CACO-2 | -4.686 |
| MDCK | 0.0000184 |
| BBB | 0.568 |
| PPB | 0.938887 |
| VDSS | 0.55 |
| FU | 0.0403065 |
| CYP1A2-inh | 0.935 |
| CYP1A2-sub | 0.909 |
| CYP2c19-inh | 0.934 |
| CYP2c19-sub | 0.404 |
| CYP2c9-inh | 0.766 |
| CYP2c9-sub | 0.876 |
| CYP2d6-inh | 0.531 |
| CYP2d6-sub | 0.885 |
| CYP3a4-inh | 0.478 |
| CYP3a4-sub | 0.474 |
| CL | 5.477 |
| T12 | 0.527 |
| hERG | 0.068 |
| Ames | 0.886 |
| ROA | 0.043 |
| SkinSen | 0.319 |
| Carcinogencity | 0.889 |
| EI | 0.818 |
| Respiratory | 0.264 |
| NR-Aromatase | 0.036 |
| Antiviral | No |
| Prediction | 0.743786 |